{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:17:17Z","timestamp":1791062237878,"version":"4.1.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T00:00:00Z","timestamp":1196812800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0001260","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T00:00:27Z","timestamp":1196812827000},"page":"e1260","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["HIV-Infected Children Living in Central Africa Have Low Persistence of Antibodies to Vaccines Used in the Expanded Program on Immunization"],"prefix":"10.1371","volume":"2","author":[{"given":"Mathurin C.","family":"Tejiokem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionela","family":"Gouandjika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydie","family":"B\u00e9niguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claire Endegue","family":"Zanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Tene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean C.","family":"Gody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Njamkepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anfumbom","family":"Kfutwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Penda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bilong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Rousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Pouillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Tangy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Baril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2007,12,5]]},"reference":[{"key":"ref1","year":"2006"},{"key":"ref2","article-title":"Immunization service delivery and accelerated disease control. Vaccine Preventable Diseases."},{"key":"ref3","first-page":"61","article-title":"Immunization of children at risk of infection with human immunodeficiency virus.","volume":"81","author":"WJ Moss","year":"2003","journal-title":"Bull World Health Organ"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/1570162043351084","article-title":"Immunization for persons infected with human immunodeficiency virus.","volume":"2","author":"C Pancharoen","year":"2004","journal-title":"Curr HIV Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1128\/JCM.43.6.2709-2717.2005","article-title":"Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.","volume":"43","author":"F Rouet","year":"2005","journal-title":"J Clin Microbiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1086\/429963","article-title":"Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples.","volume":"191","author":"S Scott","year":"2005","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jviromet.2005.08.001","article-title":"Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay.","volume":"131","author":"BJ Cohen","year":"2006","journal-title":"J Virol Methods"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0264-410X(91)90224-T","article-title":"Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal.","volume":"9","author":"E Relyveld","year":"1991","journal-title":"Vaccine"},{"key":"ref9","first-page":"44","article-title":"Neutralisation test for polio antibodies","year":"1997"},{"key":"ref10"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(03)14793-9","article-title":"Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis.","volume":"362","author":"D Dunn","year":"2003","journal-title":"Lancet"},{"key":"ref12","first-page":"11","article-title":"The development of MUAC-for-age reference data recommended by a WHO Expert Committee.","volume":"75","author":"M de Onis","year":"1997","journal-title":"Bull World Health Organ"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/tropej\/fmk002","article-title":"HIV-1 Infection as a risk factor for incomplete childhood immunization in Zambia.","volume":"52","author":"RW Setse","year":"2006","journal-title":"J Trop Pediatr"},{"key":"ref14","first-page":"329","article-title":"Evaluating the impact of the HIV pandemic on measles control and elimination.","volume":"83","author":"RF Helfand","year":"2005","journal-title":"Bull World Health Organ"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(07)60107-X","article-title":"Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study.","volume":"369","author":"LJ Wolfson","year":"2007","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0022-3476(94)70125-3","article-title":"Responses to measles immunization in children infected with human immunodeficiency virus.","volume":"125","author":"BJ Rudy","year":"1994","journal-title":"J Pediatr"},{"key":"ref17","first-page":"653","article-title":"Measles antibody in vaccinated human immunodeficiency virus type 1-infected children.","volume":"97","author":"SM Arpadi","year":"1996","journal-title":"Pediatrics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2223\/JPED.360","article-title":"Search of antimeasles antibodies in HIV-infected children after basic immunization.","volume":"77","author":"CR Lindgren-Alves","year":"2001","journal-title":"J Pediatr (Rio J)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/archpedi.1992.02160170030011","article-title":"Safety and immunogenicity of high-dose Edmonston-Zagreb measles vaccine in children with HIV-1 infection. A cohort study in Kigali, Rwanda.","volume":"146","author":"P Lepage","year":"1992","journal-title":"Am J Dis Child"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0140-6736(91)91771-L","article-title":"Child mortality after high-titre measles vaccines: prospective study in Senegal.","volume":"338","author":"M Garenne","year":"1991","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ije\/28.2.341","article-title":"The effect of human immunodeficiency virus-1 infection and stunting on measles immunoglobulin-G levels in children vaccinated against measles in Uganda.","volume":"28","author":"P Waibale","year":"1999","journal-title":"Int J Epidemiol"},{"key":"ref22","first-page":"e16","article-title":"Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and Chad.","volume":"4","author":"RF Grais","year":"2007"},{"key":"ref23","first-page":"e24","article-title":"Measles still has a devastating impact in unvaccinated populations.","volume":"4","author":"WJ Moss","year":"2007"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0264-410X(99)00396-5","article-title":"Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination.","volume":"18","author":"N Bautista-Lopez","year":"2000","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/323346","article-title":"Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months.","volume":"184","author":"H Gans","year":"2001","journal-title":"J Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/424571","article-title":"Decrease in measles virus-specific CD4 T cell memory in vaccinated subjects.","volume":"190","author":"D Naniche","year":"2004","journal-title":"J Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00006454-199502000-00013","article-title":"Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children.","volume":"14","author":"I Al-Attar","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00042560-199510050-00007","article-title":"Abnormalities of measles antibody response in human immunodeficiency virus type 1 (HIV-1) infection.","volume":"10","author":"PA Brunell","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1542\/peds.2005-2616","article-title":"Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.","volume":"118","author":"V Bekker","year":"2006","journal-title":"Pediatrics"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(04)17140-7","article-title":"Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis.","volume":"364","author":"ML Newell","year":"2004","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nm1380","article-title":"Pathogenesis of HIV infection: what the virus spares is as important as what it destroys.","volume":"212","author":"Z Grossman","year":"2006","journal-title":"Nat Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ni1316","article-title":"HIV disease: fallout from a mucosal catastrophe?","volume":"7","author":"JM Brenchley","year":"2006","journal-title":"Nat Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00006454-199606000-00003","article-title":"Growth of human immunodeficiency type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to 1993.","volume":"15","author":"P Lepage","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"E77","DOI":"10.1542\/peds.106.6.e77","article-title":"Morbidity among human immunodeficiency virus-1-infected and -uninfected African children.","volume":"106","author":"TE Taha","year":"2000","journal-title":"Pediatrics"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0140-6736(07)60670-9","article-title":"Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study.","volume":"369","author":"LM McNally","year":"2007","journal-title":"Lancet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1182\/blood.V96.12.3866","article-title":"T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV.","volume":"96","author":"M Clerici","year":"2000","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/QAD.0b013e328011d7d3","article-title":"Immune activation and normal levels of endogenous antivirals are seen in healthy adolescents born of HIV-infected mothers.","volume":"21","author":"A Vigano","year":"2007","journal-title":"AIDS"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/00002030-199212000-00007","article-title":"Immunization in children with HIV seropositivity at birth: antibody response to polio vaccine and tetanus toxoid.","volume":"6","author":"M Barbi","year":"1992","journal-title":"AIDS"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-3476(06)80007-7","article-title":"Safety and immunogenicity of bacille Calmette-Guerin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1.","volume":"122","author":"RW Ryder","year":"1993","journal-title":"J Pediatr"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM200009143431103","article-title":"Trial of a supplemental dose of four poliovirus vaccines.","volume":"343","author":"RW Sutter","year":"2000","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0264-410X(97)00001-7","article-title":"Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants.","volume":"15","author":"H Triki","year":"1997","journal-title":"Vaccine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1097\/00002030-200409240-00006","article-title":"Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d'Ivoire.","volume":"18","author":"P Fassinou","year":"2004","journal-title":"AIDS"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1086\/425739","article-title":"Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1.","volume":"39","author":"A Faye","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/01.aids.0000200529.64113.3e","article-title":"Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection.","volume":"20","author":"E Chiappini","year":"2006","journal-title":"AIDS"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0001260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T04:18:00Z","timestamp":1588133880000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0001260"}},"subtitle":[],"editor":[{"given":"Landon","family":"Myer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,12,5]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2007,12,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0001260","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,5]]}}}